CervoMed Inc. (CRVO) vs SCYNEXIS, Inc. (SCYX)
A side-by-side comparison of CervoMed Inc. and SCYNEXIS, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRVO
CervoMed Inc.
$3.34HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SCYX
SCYNEXIS, Inc.
$4.84HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CRVO vs SCYX
growth of $100 · dividends reinvested · last 10yCRVO -100.0% (-54.0%/yr)SCYX -98.7% (-35.2%/yr)SCYX compounded faster over this window
Log scale — wide-divergence pair
CRVO SCYX
CRVO vs SCYX: by the numbers
- •CRVO is the larger company ($31M vs $30M market cap).
- •Both run net losses; SCYX's is the smaller (-53.27% vs -9408.76% net margin).
Metrics side by side
Valuation
| Metric | CRVO | SCYX |
|---|---|---|
| P/S ratio | 95.87 | 1.58 |
| P/B ratio | 1.35 | 0.45 |
Profitability
| Metric | CRVO | SCYX |
|---|---|---|
| Gross margin | 0.00% | 100.00% |
| Operating margin | 0.00% | -78.03% |
| Net margin | -9408.76% | -53.27% |
| ROE | -132.18% | -15.29% |
| ROIC | -135.73% | -32.68% |
Growth (annualized)
| Metric | CRVO | SCYX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 9.78% |
| Total return CAGR (5Y) | -38.25% | -34.13% |
Frequently asked
- How have CRVO and SCYX total returns compared?
- Over the past 10 years, CRVO delivered -53.96% and SCYX delivered -35.18% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.